Effects of menthol ice and frozen saline on thirst and sore throat after lumbar disc surgery

The Effect of Menthol Ice and Frozen Saline Applications on Patients' Thirst and Sore Throat After Lumbar Disc Surgery

Not applicable Interventional Istanbul University - Cerrahpasa · NCT06939842

This study tests whether using menthol ice and frozen saline can help reduce thirst and sore throat in patients after lumbar disc surgery.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment102 (estimated)
Ages18 Years and up
SexAll
SponsorIstanbul University - Cerrahpasa Academic / other
Locations1 site (Istanbul)
Trial IDNCT06939842 on ClinicalTrials.gov

What this trial studies

This study investigates the impact of menthol ice and frozen saline applications on postoperative thirst and sore throat in patients who have undergone lumbar disc surgery. It addresses common complications arising from general anesthesia and endotracheal intubation, which can lead to discomfort such as intense thirst and sore throat. The study aims to enhance patient comfort and reduce complications by evaluating these interventions in the early postoperative period. Participants will be monitored for their symptoms and overall recovery experience following surgery.

Who should consider this trial

Good fit: Ideal candidates include adults aged 18 and over who have undergone lumbar disc surgery under general anesthesia and have not yet started oral intake.

Not a fit: Patients with a pre-existing sore throat or those allergic to menthol may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could significantly improve postoperative comfort for patients undergoing lumbar disc surgery by effectively managing thirst and sore throat.

How similar studies have performed: While the specific interventions of menthol ice and frozen saline are novel, similar studies addressing postoperative discomfort have shown promising results.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Knowing how to read, write and speak Turkish
* Having no obstacle in understanding and communicating the information given
* Agreeing to participate in the research verbally and in writing after being informed about the research
* Ages 18 and over
* Those who underwent surgery under general anesthesia
* Those who have not yet started oral intake in the postoperative period
* Without menthol allergy
* According to the American Society of Anesthesiologists (ASA) classification; Class I, II and III, Normal healthy patient (ASA I); Patient with mild systemic disease (ASA II); Patient with serious systemic disease that does not affect daily activities (ASA III)
* Having no sore throat before surgery
* As a result of the evaluation made with the Safety Protocol for Management Thirst in the Early Postoperative Period , patients who provide appropriate conditions for ice application (the individual must be conscious and oriented after the surgery, the airway must be open with coughing, swallowing and breathing, and there is no nausea or vomiting)

Exclusion Criteria:

* Those who have severe nausea and vomiting at the time of application
* Those with a change in consciousness status/acute confusion after surgical intervention
* Those with chronic disease/diseases related to Ear-Nose-Throat Diseases
* Patients with difficult intubate
* Patients with psychiatric problems

Where this trial is running

Istanbul

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions ThirstSore ThroatLumbar Disc DiseaseMentholIce
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.